U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.
Source link
Trending
- Forgotten 3-time WWE champion subtly announces he’s returning to AEW at Redemption 2026
- Can working from bed affect blood sugar levels?
- Are brain waves the next unlock for physical AI?
- More Indian EVs head to distant shores as Maruti, Tata, M&M drive 14-fold export surge
- Rajasthan farmers object to GI on Unjha jeera and saunf | India News
- Hilaria Baldwin stuns in bikini workout video as fans praise mom of 7
- Sheamus names former WWE champion as someone he wanted to work with
- Trilateral critical mineral deals, wider air pact key to India-UAE ties ahead, says UAE Minister
